Patents Assigned to MEIOGENIX
  • Meiotic promotors and uses thereof
    Patent number: 11795465
    Abstract: The present invention relates to new transcriptional promoters that are functional during meiosis. It thus provides new tools, methods and compositions for the expression of proteins during meiosis in a eukaryotic cell, and more particularly in a plant cell.
    Type: Grant
    Filed: May 23, 2019
    Date of Patent: October 24, 2023
    Assignees: MEIOGENIX, INTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT, UNIVERSITE CLAUDE BERNARD LYON 1, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, ECOLE NORMALE SUPERIEURE DE LYON
    Inventors: Giacomo Bastianelli, Alain Nicolas, Peter Rogowsky
  • Method for inducing targeted meiotic recombinations
    Patent number: 11248240
    Abstract: The present invention relates to a fusion protein comprising a Cas9 domain and a Spo11 domain, as well as the use of this protein to induce targeted meiotic recombinations in a eukaryotic cell.
    Type: Grant
    Filed: January 29, 2016
    Date of Patent: February 15, 2022
    Assignees: MEIOGENIX, INSTITUT CURIE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, SORBONNE UNIVERSITE
    Inventors: Giacomo Bastianelli, Alexandre Serero, Alain Nicolas
  • METHOD FOR INDUCING TARGETED MEIOTIC RECOMBINATIONS
    Publication number: 20180023091
    Abstract: The present invention relates to a fusion protein comprising a Cas9 domain and a Spo11 domain, as well as the use of this protein to induce targeted meiotic recombinations in a eukaryotic cell.
    Type: Application
    Filed: January 29, 2016
    Publication date: January 25, 2018
    Applicants: MEIOGENIX, INSTITUT CURIE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6)
    Inventors: GIACOMO BASTIANELLI, ALEXANDRE SERERO, ALAIN NICOLAS